siRNA-mediated silencing of STIM1/Orai1 expression or pharmacological SOCE inhibition in GBM cells have been shown to suppress cell growth [31,32], migration [33] and invasion [25], supporting the investigation of Ca2+ signalling blockers as potential novel therapeutic tools for GBM treatment. This evidence concerns the gene STIM1 and glioblastoma.